Navigation Links
Cancer Experts Meet in Boston to Discuss a Promising Approach to Treating the Disease
Date:10/21/2013

CAMBRIDGE, Mass., Oct. 21, 2013 /PRNewswire/ -- Academics, healthcare providers, and pharmaceutical industry professionals are gathered in Boston to discuss the latest advances in cancer research. The evening of Tuesday, October 22, those professionals are invited to attend a symposium that will explore one of the most exciting targets in cancer treatment, a protein called hypoxia-inducible factor-1a, or HIF-1a.

The role of HIF-1a in solid tumors has been well documented. It is often present in solid tumors where hypoxic, or low oxygen, conditions are common, and its presence may be increased by anti-angiogenic medicines and radiation. Because HIF-1a can promote resistance, leaders in government, academia, and industry have long sought an effective HIF-1a inhibitor. This week, experts will discuss whether the potential of HIF-1a inhibition is soon to become a reality.

The pre-clinical panel features Giovanni Melillo, MD, of AstraZeneca and formerly of the National Cancer Institute; Sarah Conley, PhD, of MedImmune and formerly of the Max Wicha Lab at the University of Michigan; Amato Giaccia, PhD, of Stanford University; and Robert Kerbel, PhD, of the University of Toronto.

The clinical panel features William Kaelin, MD, of Harvard Medical School; Laura Benjamin, PhD, of Eli Lilly; Mark Dewhirst, DVM, PhD, of Duke University School of Medicine; and Steve Keefe, MD, of the Abramson Cancer Center at the University of Pennsylvania.

Oliver Fetzer, PhD, President and CEO of symposium sponsor, Cerulean Pharma, will welcome attendees, and Robert A. Weinberg, PhD, of the Massachusetts Institute of Technology, will provide closing remarks. WHO: Academics, professionals, and journalists interested in the latest research on the HIF-1a protein and the advances that illustrate its value as a target for new medicinesWHAT: HIF-1a: Ready for Prime Time? includes pre-clinical and clinical panels, closing remarks, a poster exhibition, and a dinner receptionWHEN: Tuesday, October 22, 2013, from 5:30 p.m. to 9:30 p.m.WHERE: Joseph B. Martin Conference Center, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115REGISTER: Online at www.HIFSymposium.com, via email at register@hospicom.us with "HIF Symposium" in the subject line, or by phone at 845-265-2155 specifying "HIF Symposium"; please note institution, degree, and phone number when registering; there is no fee 

Media Contact: 
Laura Kempke or Kristin Villiotte 
Schwartz MSL 
cerulean@schwartzmsl.com 
+1 781-684-0770


'/>"/>
SOURCE Cerulean Pharma
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Potential Treatment for Three Chemotherapy Resistant Cancers
2. Data Presented For ENMD-2076 In Preclinical Models Of Triple-Negative Breast Cancer
3. Nucletron, an Elekta Company, Receives U.S. FDA 510(k) Clearance for Esteya Electronic Brachytherapy System for Treating Skin Cancer
4. IceCure Enters a New High-Potential Market: The company received $100K-order for cryoablation consoles and probes to be used in a clinical study for the treatment of lung cancer
5. Sedationless Colonoscopy Option May Increase Colorectal Cancer Screening Compliance
6. Hologic to Mark Start of Breast Cancer Awareness Month with NASDAQ Opening Bell Ceremony
7. First urine-based cancer mutation monitoring test available from Trovagene
8. Warnings for Hepatitis B Reactivation in Cancer Patients Welcomed by the American Association for the Study of Liver Diseases
9. Varians Calypso Tumor Tracking System Used in Lung, Stomach and Prostate Cancer Treatments at Leading European Cancer Center
10. Halozyme Presents PEGPH20 Phase 1b Clinical Trial Data at European Cancer Congress 2013
11. Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer - International White Paper Launched at European Cancer Congress 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2019)... CHATTANOOGA, Tenn. (PRWEB) , ... December 13, 2019 ... ... Randall help patients suffering from gum disease in Chattanooga, TN receive ... disease treatment into their practice, Drs. Felts and Randall provide effective gum disease ...
(Date:12/9/2019)... ... December 09, 2019 , ... Medpricer™, which ... across purchased services contracts, today announced its latest partnership with San Diego-based Sharp ... with four acute care hospitals, three specialty hospitals, three affiliated medical groups, 22 ...
(Date:12/8/2019)... ... December 07, 2019 , ... ... medical affairs, regulatory, and technology-enabled solutions, announced that MAIA Pharmaceuticals, Inc. (MAIA), a ... products has chosen Soterius and its partners in Europe, to support their regulatory ...
Breaking Medicine Technology:
(Date:12/8/2019)... ... December 08, 2019 , ... Intelligent.com, a ... Top 26 Logistics Degree Programs for 2020. The comprehensive research guide is based ... program is evaluated based on curriculum quality, graduation rate, reputation, and post-graduate employment. ...
(Date:12/6/2019)... ... 2019 , ... Connecticut is home to a growing healthcare ... On December 12th, Hartford Business Journal will recognize eight individuals and organizations who ... the Hartford Marriott. , “We are fortunate to have so many great providers ...
(Date:12/6/2019)... ... December 06, 2019 , ... COMPLIANCY GROUP is ... the Wyoming Medical Society. Compliancy Group is dedicated to educating and assisting Wyoming ... to adhere to the standards set forth by the Health Insurance Portability and ...
(Date:12/5/2019)... ... December 05, 2019 , ... A cohort of ... technology to help their patients more easily detect ruptured silicone gel implants. Dr. ... study and reporting on his experience. While the FDA currently recommends regular MRI ...
(Date:12/5/2019)... ... December 05, 2019 , ... ... from launching exceptional products that help people embrace, achieve, and maintain a healthy ... never been more committed to our mission of impacting world health, so it’s ...
Breaking Medicine News(10 mins):